Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paxman Scalp Cooling System in Metastatic Breast Cancer
NCT04986579Phase 2Recruiting
- Sponsor
- Dana-Farber Cancer Institute
- Start
- Oct 2021
- Primary completion
- Jun 2028
- Countries
- 1
01
Overview
Phase 2, open-label trial in Chemotherapy-induced alopecia (CIA) (6 arms), sponsored by Dana-Farber Cancer Institute. Primary endpoint: Hair Loss Rate up to 2 years. Started Oct 2021; status: recruiting.
02
Conditions
Chemotherapy-induced alopecia (CIA)
Beyond the preview
Go deeper on NCT04986579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04986579.